NSE › Healthcare

Strides Pharma Science Limited (STAR)

NSE · Healthcare · Drug Manufacturers - Specialty & Generic

₹1,028.50+0.83%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
₹1,323 cr
Revenue YoY
+11.2%
Net profit
₹127 cr
Profit YoY
+54.4%
EPS
₹-13.46
EPS estimate
₹4.20
Net margin
9.6%

EPS came in at -13.46 against a street estimate of 4.20 — a miss of 420.5%.

Key statistics

Market cap
₹9,494 cr
P/E
15.5
Forward P/E
9.4
P/B
3.04
Book value
₹337.15
EPS (TTM)
₹66.52
52-week high
₹1,225.26
52-week low
₹765.07
50-day MA
₹1,079.45
200-day MA
₹972.54
Beta
0.34

Analyst view

with an average price target of ₹1,338.67.

Shareholding

Promoters
30.83%
Institutions
29.20%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Strides Pharma Science Limited — free to start.

Google PlayApp Store

Other Healthcare companies

Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedApollo Hospitals Enterprise LimitedCipla LimitedZydus Lifesciences LimitedLupin LimitedMax Healthcare Institute LimitedMankind Pharma LtdLaurus Labs LimitedLenskart Solutions LtdDr. Reddy's Laboratories Limited

Data updated 2026-08-05.